miR-199b-5p在头颈癌细胞中的表达及对细胞增殖和侵袭能力的影响

doi:10.19439/j.sjos.2018.03.010

上海口腔医学 ›› 2018, Vol. 27 ›› Issue (3): 265-269.doi: 10.19439/j.sjos.2018.03.010

miR-199b-5p在头颈癌细胞中的表达及对细胞增殖和侵袭能力的影响

王茜，李光辉，郭嘉，孙强

郑州大学第一附属医院口腔医学中心，河南郑州 450052

收稿日期:2017-03-06 修回日期:2017-08-10 出版日期:2018-07-20 发布日期:2018-07-20
通讯作者: 孙强，E-mail：franklin1082@163.com
作者简介:王茜（1983-），女，博士，主治医师，E-mail：sissy9288@163.com
基金资助:
国家自然科学基金（31400839，81402231）；河南省科技厅基础研究和前沿技术研究项目（142300410315）；郑州市口腔颌面外科院士工作站资助项目（152PYSGZ040）

miR-199b-5p inhibits proliferation and invasion of head and neck cancer cells

WANG Xi, LI Guang-hui, GUO Jia, SUN Qiang.

Department of Stomatology, the First Affiliated Hospital of Zhengzhou University. Zhengzhou 450052, Henan Province, China

Received:2017-03-06 Revised:2017-08-10 Online:2018-07-20 Published:2018-07-20

摘要/Abstract

摘要： 目的： 明确miR-199b-5p差异表达在头颈部鳞状细胞癌（HNSCC）发生、发展中的作用并探讨其生物学功能。方法： 检测128例HNSCC组织中miR-199b-5p的表达，通过Kaplan-Meier生存分析，分析临床病理参数与miR-199b-5p表达水平之间的关系。通过miRNA异常表达对HNSCC细胞生长、侵袭和迁移能力以及克隆形成的影响，检测HNSCC细胞中miRNA的功能。采用SPSSl9.0软件包对数据进行t检验。结果： 在79例淋巴结转移的HNSCC组织中，miR-199b-5p的表达水平为1.68±0.21；在49例非淋巴结转移的HNSCC组织中，其表达水平为2.64±0.24，差异显著（P=0.001）。在HNSCC患者中，高表达miR-199b-5p的患者总体存活率显著增高（P=0.01），且高表达水平的miR-199b-5p可以显著抑制头颈鳞癌细胞的侵袭和转移。结论： 作为抑癌基因，miR-199b-5p在HNSCC的发生、发展中起着关键作用。

关键词: miR-199b-5p, 头颈鳞癌, 转移, 侵袭

Abstract: PURPOSE: This study identified the differentially expressed miR-199b-5p in the progressing of head and neck squamous cell carcinoma(HNSCC) and investigated its biological characters. METHODS: The expression of miR-199b-5p in 128 HNSCC tissues samples was evaluated. The association between clinicopathological parameters and the expression levels of the candidated miRNAs was analyzed by using Kaplan-Meier survival analysis. Cell growth, invasion and migration potential, and clone formation were observed to detect the functions of the miRNAs in HNSCC cells. Statistical analysis was performed using SPSS 19.0 software package. RESULTS: In 79 HNSCC tissues with cervical lymph node metastasis, the expression level of miR-199b-5p was 1.68±0.21; while the expression level was 2.64±0.24 in 28 tissues without lymph node metastasis (P=0.001). In patients with HNSCC, lower level of miR-199b-5p expression significantly correlated with worse overall survival rate (P=0.01). Overexpression of miR-199b-5p inhibited HNSCC cell proliferation and invasion. CONCLUSIONS: miR-199b-5p plays a key role in cell invasion and metastasis and its expression correlated with overall survival in patients with HNSCC.

Key words: miR-199b-5p, HNSCC, Metastasis, Invasion

中图分类号:

R739.8

王茜，李光辉，郭嘉，孙强. miR-199b-5p在头颈癌细胞中的表达及对细胞增殖和侵袭能力的影响[J]. 上海口腔医学, 2018, 27(3): 265-269.

WANG Xi, LI Guang-hui, GUO Jia, SUN Qiang.. miR-199b-5p inhibits proliferation and invasion of head and neck cancer cells[J]. Shanghai Journal of Stomatology, 2018, 27(3): 265-269.

参考文献

[1] Sun Q, Chen S, Zhao X, et al. Dysregulated miR-645 affects the proliferation and invasion of head and neck cancer cell [J]. Cancer Cell Int, 2015, 15(1): 87-91.
[2] Cui J, Lu K, Shi Y, et al. Integrated and comparative miRNA analysis of starvation-induced autophagy in mouse embryonic fibroblasts [J]. Gene, 2015, 571(2): 194-204.
[3] Gao D, Zhang Y, Zhu M, et al. miRNA expression profiles of HPV-infected patients with cervical cancer in the Uyghur population in China [J]. PLoS One, 2016, 11(10): e0164701.
[4] Doldi V, Callari M, Giannoni E, et al. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation [J]. Oncotarget, 2015, 6(31): 31441-31460.
[5] Gambari R, Brognara E, Spandidos DA, et al. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Nuew trends in the development of miRNA therapeutic strategies in oncology (Review) [J]. Int J Oncol, 2016, 49(1): 5-32.
[6] Doecke JD, Wang Y, Baggerly K. Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types[J]. Cancer Genet, 2016, 209(10): 463-473.
[7] van Ginkel JH, Huibers MM, Noorlag R, et al. Liquid biopsy: a future tool for posttreatment surveillance in head and neck cancer? [J]. Pathobiology, 2017, 80(3): 185-191.
[8] Boeckx C, Op de Beeck K, Wouters A, et al. Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins [J]. Cancer Lett, 2014, 354(2): 365-377.
[9] Takenaka Y, Takemoto N, Yasui T, et al. Transaminase activity predicts survival in patients with head and neck cancer [J]. PLoS One, 2016, 11(10): e0164057.
[10] Li S, Zhang J, Wan X. Role of miRNAs in endometrial cancer [J]. Histol Histopathol, 2015, 30(5): 539-548.
[11] Du P, Dai F, Chang Y, et al. Role of miR-199b-5p in regulating angiogenesis in mouse myocardial microvascular endothelial cells through HSF1/VEGF pathway [J]. Environ Toxicol Pharmacol, 2016, 47: 142-148.
[12] Fang C, Wang FB, Li Y, et al. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients [J]. Biomed Pharmacother, 2016, 84(6): 1189-1193.
[13] Scrima M, Zito Marino F, Oliveira DM, et al. Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients [J]. J Cancer, 2017, 8(2): 227-239.
[14] Gidl?f O, van der Brug M, Ohman J, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression [J]. Blood, 2013, 121(19): 3908-3917, S1-26.
[15] Blenkiron C, Miska EA. miRNAs in cancer: approaches, aetiology, diagnostics and therapy[J]. Hum Mol Genet, 2007, 16 (R1): R106-113.
[16] Lamperska KM, Kozlowski P, Kolenda T, et al. Unpredictable

miR-199b-5p在头颈癌细胞中的表达及对细胞增殖和侵袭能力的影响

miR-199b-5p inhibits proliferation and invasion of head and neck cancer cells

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	郝妍, 白相宇, 霍峰, 陈喜波. 下调SETDB1通过SOX7甲基化抑制口腔癌上皮-间充质转化、侵袭和转移的机制探讨[J]. 上海口腔医学, 2024, 33(1): 30-35.
[2]	刘文静, 李梦琦, 崔祥, 汪俊兰. circ_0000326靶向miR-567对口腔鳞状细胞癌HSC3细胞增殖、侵袭及迁移的调控效应[J]. 上海口腔医学, 2023, 32(6): 590-596.
[3]	刘芸, 陈浩月, 米静, 王菲菲, 万光勇, 崔超. 芍药苷对舌鳞癌CAL27细胞的抑制作用及机制探讨[J]. 上海口腔医学, 2023, 32(6): 597-602.
[4]	叶璞, 黄兴鸿, 张伟, 吴萌, 俞辉明. cN0期舌鳞癌患者颈淋巴结转移的相关因素及预后分析[J]. 上海口腔医学, 2022, 31(5): 540-543.
[5]	高远, 陈杰, 王高琦, 李云凯, 卞翠荣. 种植体-基台连接设计对基台与基台螺丝受力影响的三维有限元分析[J]. 上海口腔医学, 2021, 30(5): 481-487.
[6]	黄丹妮, 陈文鑫, 熊浩峰, 胡鑫, 毛婷, 苏彤. 口腔鳞状细胞癌患者术后服用二甲双胍对预后的影响[J]. 上海口腔医学, 2021, 30(1): 61-65.
[7]	徐竹青, 张馨予, 王少如, 李涛, 董刚, 李凤梅, 郑建金, 王云英, 徐晓娜. 人骨髓间充质干细胞对舌鳞癌细胞系Cal-27侵袭作用的影响[J]. 上海口腔医学, 2020, 29(2): 155-161.
[8]	周璐, 龚霞, 熊屏. 载药脂质体-微泡复合物超声导向治疗头颈鳞癌的体外实验研究[J]. 上海口腔医学, 2020, 29(2): 168-173.
[9]	冯小东, 易文, 殷卫红. 过表达miR-218对舌鳞癌细胞系SCC-4和SCC-9的增殖和侵袭的影响[J]. 上海口腔医学, 2019, 28(4): 373-377.
[10]	陈祺, 王旭, 余优成, 魏魁杰. 沉默LASP1对口腔鳞癌细胞生物学行为及3种抗肿瘤药物IC₅₀的影响[J]. 上海口腔医学, 2019, 28(1): 13-19.
[11]	陈洁, 季平, 苏雷震, 李显. 沙利霉素对舌鳞癌细胞体外增殖、侵袭和迁移能力的影响[J]. 上海口腔医学, 2019, 28(1): 20-24.
[12]	唐曹敏, 乔翔鹤, 李春洁, 闫恺潇, 林洁, 王晓毅. 增强CT对头颈部鳞癌患者颈部淋巴结包膜外侵犯的诊断效能：系统评价与meta分析[J]. 上海口腔医学, 2018, 27(6): 668-672.
[13]	孟雪, 齐晓宇, 王秋旭, 刘维贤. HBXIP对腺样囊性癌细胞株ACC-M生物学功能及PI3K/Akt信号通路的影响[J]. 上海口腔医学, 2017, 26(4): 389-394.
[14]	蒋丽兰, 赵娅军, 李勇. TGF-βRⅡ和NF-κB在口腔鳞状细胞癌的表达及临床意义[J]. 上海口腔医学, 2016, 25(6): 729-733.
[15]	黄晓红, 许亮, 林珊. 双层透明压膜片转移托盘间接粘结托槽的效果评价[J]. 上海口腔医学, 2016, 25(6): 734-737.